Genetic studies have highlighted the role of polymorphisms in the IREB2 and CHRNA5 genes in COPD susceptibility; however, their impact varies across populations, clinical phenotypes, and additional factors such as smoking. This evidence concerns the gene CHRNA5 and chronic obstructive pulmonary disease.